(Q35601582)

9 August 2017

1 reference

title

Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

2

Rachel Schiff

1 reference

9 August 2017

C Kent Osborne

1

1 reference

9 August 2017

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

12

1 reference

9 August 2017

362-367

1 reference

9 August 2017

6

1 reference

The phosphoinositide 3-kinase pathway

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

The Raf/MEK/ERK pathway: new concepts of activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Cellular functions of plasma membrane estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

The role of mitogen-activated protein (MAP) kinase in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Estrogen receptor beta in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Selective estrogen receptor modulators: structure, function, and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Use of pure antioestrogens to elucidate the mode of action of oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Estrogen receptor pathways to AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Proximal events in signaling by plasma membrane estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

1 reference

7 January 2021

Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Transcriptional regulation by MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

The predictive value of HER2 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900137-1

7 January 2021

10.1016/S0960-9776(03)00137-1

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14659106